Abstract Details
|
Samantha K. Holden, MD, MS, FAAN
(University of Colorado School of Medicine)
PRESENTER |
Dr. Holden has nothing to disclose. |
| No disclosure on file | |
| Glenn T. Stebbins, PhD (Rush University Medical Center) | Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS. |
| Bryan A. Bernard, PhD (Rush University Medical Center) | Dr. Bernard has nothing to disclose. |
| Christopher Goetz, MD, FAAN (Rush University Medical Center) | The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. |
| Jennifer G. Goldman, MD, MS, FAAN | Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation Scientific Advisory Board. The institution of Dr. Goldman has received research support from Michael J. Fox Foundation. The institution of Dr. Goldman has received research support from Parkinson's Foundation. |
| Matthew Klein | Matthew Klein has received personal compensation for serving as an employee of PTC Therapeutics. Matthew Klein has stock in PTC Therapeutics. Matthew Klein has received publishing royalties from a publication relating to health care. |